Cardiol Therapeutics Inc., 2025-11-04
An SEC Form D private-offering notice from Oakville, ON, Canada, a $8,471,875 filer-stated offering target in Biotech. Filed 2025-11-04. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical-stage life sciences company developing cannabidiol-based CardiolRx and related therapies to treat inflammatory heart conditions such as pericarditis, myocarditis, and heart failure.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Paretor LLC, 2025-11-04, $250K, Watertown, MA
- Medsyn Biopharma LLC, 2025-11-04, $11.5M, Northville, MI
- Gregor Diagnostics, Inc., 2025-11-04, $250K, Dallas, TX
- Oxbridge Clinical Inc., 2025-11-03, $4.5M, Boston, MA
- iQure Pharma Inc., 2025-11-03, $1.8M, Skillman, NJ
- BiomeSense, Inc., 2025-11-03, $7.2M, Chicago, IL
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.